Diagnosis of colorectal hepatic metastases: Comparison of contrast‐enhanced CT, contrast‐enhanced US, superparamagnetic iron oxide‐enhanced MRI, and gadoxetic acid‐enhanced MRI

To compare the diagnostic accuracy of contrast‐enhanced computed tomography (CE‐CT), contrast‐enhanced ultrasonography (CE‐US), superparamagnetic iron oxide‐enhanced magnetic resonance imaging (SPIO‐MRI), and gadoxetic acid‐enhanced MRI (Gd‐EOB‐MRI) in the evaluation of colorectal hepatic metastases.

[1]  W. Sensakovic,et al.  ACR Appropriateness Criteria. , 2010, Current problems in cancer.

[2]  J. Stoker,et al.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.

[3]  U. Motosugi,et al.  Diagnosis of colorectal hepatic metastases: Contrast‐enhanced ultrasonography versus contrast‐enhanced computed tomography versus superparamagnetic iron oxide‐enhanced magnetic resonance imaging with diffusion‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[4]  K. Doi,et al.  Improved detection of hepatic metastases with contrast-enhanced low mechanical-index pulse inversion ultrasonography during the liver-specific phase of sonazoid: observer performance study with JAFROC analysis. , 2009, Academic radiology.

[5]  M. Morimoto,et al.  Sonazoid‐Enhanced Ultrasonography for Evaluation of the Enhancement Patterns of Focal Liver Tumors in the Late Phase by Intermittent Imaging With a High Mechanical Index , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[6]  U. Motosugi,et al.  Imaging of Small Hepatic Metastases of Colorectal Carcinoma: How to Use Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in the Multidetector-Row Computed Tomography Age? , 2009, Journal of computer assisted tomography.

[7]  Paula M Jacobs,et al.  Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? , 2009, Kidney international.

[8]  Kinuyo Hatanaka,et al.  Sonazoid-Enhanced Ultrasonography for Diagnosis of Hepatic Malignancies: Comparison with Contrast-Enhanced CT , 2008, Oncology.

[9]  Kinuyo Hatanaka,et al.  Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid , 2008, Intervirology.

[10]  Y. Ishida,et al.  Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases. , 2008, World journal of gastroenterology.

[11]  M. Suematsu,et al.  Mechanism of Hepatic Parenchyma-Specific Contrast of Microbubble-Based Contrast Agent for Ultrasonography: Microscopic Studies in Rat Liver , 2007, Investigative Radiology.

[12]  Fuminori Moriyasu,et al.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. , 2007, Ultrasound in medicine & biology.

[13]  Myeong-Jin Kim,et al.  Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging. , 2006, European journal of radiology.

[14]  L. Schwartz,et al.  Prospective, Blinded Comparison of Helical CT and CT Arterial Portography in the Assessment of Hepatic Metastasis from Colorectal Carcinoma , 2006, World Journal of Surgery.

[15]  Sukru Mehmet Erturk,et al.  Multiphasic contrast-enhanced multidetector-row CT of liver: contrast-enhancement theory and practical scan protocol with a combination of fixed injection duration and patients' body-weight-tailored dose of contrast material. , 2006, European journal of radiology.

[16]  Caroline Reinhold,et al.  Liver Tumor Characterization: Comparison Between Liver-specific Gadoxetic Acid Disodium-enhanced MRI and Biphasic CT-A Multicenter Trial , 2006, Journal of computer assisted tomography.

[17]  P. Kim,et al.  Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients. , 2006, AJR. American journal of roentgenology.

[18]  T. Murakami,et al.  Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. , 2006, Radiology.

[19]  M. D’Onofrio,et al.  Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence , 2006, European Radiology.

[20]  Young Kon Kim,et al.  Detection and characterization of liver metastases: 16--slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging , 2006, European Radiology.

[21]  J. Koch,et al.  Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent GD-EOB-DTPA , 2006, Acta radiologica.

[22]  Janice Ward,et al.  Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. , 2005, Radiology.

[23]  Maximilian F Reiser,et al.  Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. , 2005, Radiology.

[24]  Young Kon Kim,et al.  Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging , 2005, European Radiology.

[25]  Myeong-Jin Kim,et al.  Detection and characterization of focal hepatic lesions: Mangafodipir vs. Superparamagnetic iron oxide‐enhanced magnetic resonance imaging , 2004, Journal of magnetic resonance imaging : JMRI.

[26]  S. Kumano,et al.  Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. , 2003, AJR. American journal of roentgenology.

[27]  M. Vivarelli,et al.  Liver metastases from colorectal cancer: present surgical approach. , 2003, Hepato-gastroenterology.

[28]  C. Zuiani,et al.  Comparing Levovist-enhanced pulse inversion harmonic imaging and ferumoxides-enhanced MR imaging of hepatic metastases. , 2003, AJR. American journal of roentgenology.

[29]  A. Taschieri,et al.  Repeated liver resection for recurrent metastases from colorectal cancer. , 2003, Hepato-gastroenterology.

[30]  C. Zuiani,et al.  Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. , 2002, Radiology.

[31]  B. Nordlinger,et al.  Colorectal metastasis (liver and lung). , 2002, The Surgical clinics of North America.

[32]  B. V. Van Beers,et al.  Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. , 1996, Radiology.

[33]  M. Mack,et al.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. , 1996, Radiology.

[34]  E. Rummeny,et al.  Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. , 1996, Radiology.

[35]  B. Marincek,et al.  Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. , 1995, Radiology.

[36]  M. Taupitz,et al.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. , 1995, Radiology.

[37]  C. Metz,et al.  Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. , 1990, AJR. American journal of roentgenology.

[38]  Young Min Han,et al.  Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging. , 2010, European journal of radiology.

[39]  Maximilian F Reiser,et al.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[40]  Ethical principles for medical research involving human subjects. , 2001, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

[41]  R. Brasch,et al.  Comparison of Gd‐EOB‐DTPA and Gd‐DTPA for contrast‐enhanced MR imaging of liver tumors , 1993, Journal of magnetic resonance imaging : JMRI.